Effect of drug compliance on health care costs in newly-diagnosed dementia: Analysis of nationwide population-based data
ConclusionsThis population-based retrospective cohort study provides evidence that patients newly-diagnosed with dementia who showed higher initial drug compliance or maintained antidementia drugs (Cholinesterase inhibitors and memantine) would benefit in total health-care costs.
Source: Journal of Psychiatric Research - Category: Psychiatry Source Type: research
More News: Databases & Libraries | Dementia | Donepezil | Emergency Medicine | Health Insurance | Health Management | Insurance | International Medicine & Public Health | Namenda | Nurses | Nursing | Psychiatry | South Korea Health | Statistics | Study